Yi Chang

Dr. Yi Chang


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TZTing Zou
Ting Zou
LNLanlan Ni
Lanlan Ni
KXKeqiang Xu
Keqiang Xu
YCYi Chang
Yi Chang
Background/Objectives: The rapid emergence of multidrug-resistant (MDR) bacteria has increased the demand for non-antibiotic antibacterial strategies. Although photothermal therapy (PTT) and photodynamic therapy (PDT) are promising alternatives, each modality alone may show limited antibacterial efficacy. This study aimed to construct a flexible dual-light-responsive nanofibrous membrane integrating PTT and PDT for improved in vitro antibacterial activity against MDR bacteria. Methods: A silica nanofibrous membrane (SNF) was prepared by electrospinning followed by calcination. An Fe-doped sulfonated TpPa covalent organic framework (SCOF-Fe) was then grown in situ on the SNF surface via an interfacial diffusion strategy to obtain SNF@SCOF-Fe. The membrane was characterized in terms of morphology, structure, optical absorption, photothermal performance, Fe loading, Fe leaching, and reactive oxygen species (ROS) generation. In vitro antibacterial activity against supplier-reported MDR Escherichia coli (E. coli) and methicillin-resistant Staphylococcus aureus (MRSA) was evaluated under 420 nm, 808 nm, and dual-light (420 + 808 nm) irradiation. Results: Fe doping broadened the optical absorption of the COF-functionalized membrane into the near-infrared region and improved its photothermal response. Under dual-light irradiation, SNF@SCOF-Fe generated singlet oxygen, superoxide radicals, and hydroxyl radicals, together with a greater temperature increase than the undoped membrane. Within 15 min, SNF@SCOF-Fe achieved antibacterial rates of 99.29% against E. coli and 99.62% against MRSA. In addition, controlled dual-light cytocompatibility testing yielded 78.76% viability in L929 fibroblasts and 82.86% viability in MC38 murine colon carcinoma cells after SNF@SCOF-Fe treatment. Conclusions: SNF@SCOF-Fe combines dual-light-triggered photothermal heating and ROS generation within a flexible nanofibrous membrane and demonstrated effective in vitro antibacterial activity against two representative resistant bacteria. These findings support further investigation of SNF@SCOF-Fe as a light-responsive antibacterial membrane in relevant in vitro and in vivo models.